Havana, April 25 (RHC)-- The Cuban medication Heberprot-P to fight diabetic foot ulcers was registered by Mexico's Federal Commission for Protection against Health Risks, the authority in charge of drug registration in the country.
The Cuban pharmaceutical is administered by injections that step up the healing of deep ulcers caused by diabetes, a major cause of lower limb amputation in Mexico.
The medication, which was developed by the Havana-based Genetic Engineering and Biotechnology Center, reduces the risk of complications such as gangrene or infections.
The registration of the pharmaceutical was announced in Havana at the first meeting of the Mexico-Cuba Health Cooperation Group with the presence of Mexican Health Minister Jose Narros.
During the meeting, the two sides agreed to look at new lines of research on diseases with strong impact on the population, such as cancer, hypertension, as well as mental and genetic disorders.
Mexico registers Cuban diabetes pharmaceutical product
![](https://www.radiohc.cu/articles/8093-heberprot.jpg)
Artículos Relacionados
Comentarios
Deja un comentario
Todos los campos son requeridos
Ahora Reproduciendo
24 Horas en el mundo
A Continuación
- Desde Mi Habana
- La Trova Cubana
- Un lugar para la poesía
Más Vistas
- Cuba condena atentado contra candidato presidencial estadounidense
- Cuba por primera vez a un Mundial de Atletismo Máster
- Presidente cubano envía mensaje a encuentro de alto nivel en China
- Ministerio de Salud de Belarús otorga registro a la vacuna cubana Cimavax
- Museo Nacional de Artes Decorativas presenta Flores de Austria